LIFE – atyr pharma, inc. (US:NASDAQ)

News

aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update [Yahoo! Finance]
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k [Yahoo! Finance]
aTyr Pharma to Participate in April Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com